Cochise Clinical Research is categorized under Medical Research in Sierra Vista, AZ and active since 2006.
Cochise Clinical Research was established in 2006, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact John Herrod, Manager at the company’s single location by writing to 286 South Lenzner Avenue, Sierra Vista, Arizona AZ 85635 or by phoning (520) 459-3250. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cochise Clinical Research |
| Contact Person: | John Herrod, Manager |
| Address: | 286 South Lenzner Avenue, Sierra Vista, Arizona 85635 |
| Phone Number: | (520) 459-3250 |
| Website Address: | cochiseclinicalresearch.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417115 |
| Share This Business: |
Cochise Clinical Research was started in 2006 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact John Herrod, Manager for inquiries that concern Cochise Clinical Research by calling the company number (520) 459-3250, as your correspondence is most welcome. Additionally, the physical location of the single location of Cochise Clinical Research can be found at the coordinates 31.55119,-110.28205 as well as the street address 286 South Lenzner Avenue in Sierra Vista, Arizona 85635.
For its online presence, you may visit Cochise Clinical Research’s website at cochiseclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.